|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61F 2/91 | |
| A61L 31/16 |
| (11) | Patento numeris | 1586337 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 05252315.6 |
| Europos patento paraiškos padavimo data | 2005-04-14 | |
| (97) | Europos patento paraiškos paskelbimo data | 2005-10-19 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-06-21 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 826058 | 2004-04-15 | US |
| (72) |
Falotico, Robert, US
|
| (73) |
Cordis Corporation,
14201 N.W. 60th Avenue, Miami Lakes, Florida 33014,
US
|
| (54) | The local administration of a combination of rapamycin and 17 beta-estradiol for the treatment of vulnerable plaque |
| The local administration of a combination of rapamycin and 17 beta-estradiol for the treatment of vulnerable plaque |